Form D Explorer
Source evidence and document statusReport a field issue

Form C — Cytonus Therapeutics, Inc.

0001761468-26-000004 · filed Oct 27, 2026 · via Wefunder Portal LLC

Offering

Target
$50,000
Maximum
$1,000,000
Security type
Preferred Stock
Price per security
$12.0400
Deadline
—
Oversubscription
Accepted

Issuer

CIK
1761468
Entity
Corporation
Jurisdiction
DE
Address
10956 Deering Street
San Diego, CA 92126
Phone
—

Most recent fiscal year financials

Total assets
$2,016,065
Cash
—
Short-term debt
$1,345,542
Long-term debt
$2,652,877
Revenues
$1,275,587
COGS
$0
Taxes paid
—
Net income
$-2,244,653

View the original filing on SEC EDGAR ↗